Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2025-12-24 @ 7:23 PM
NCT ID:
NCT00807703
Eligibility Criteria:
Inclusion Criteria:
* Patients between 40-75 years old
* clinical findings consistent with idiopathic PD
* suffer from severe response fluctuations and/or dyskinesias,
* despite optimal drug treatment
* initially a good response on levodopa.
Exclusion Criteria:
* psychiatric co-morbidities and cognitive decline, e.g. dementia and psychosis, are excluded from this study.
* The mini mental state exam (MMSE) score is not allowed to be \<24.
* significant cerebral atrophy,
* causative factors of PD,
* multiple white matter lesions or
* focal brain anomalies
* Hoehn and Yahr stage of 5 at the best moment of the day.
* general contra-indications for surgery are considered as exclusion criteria, e.g. coagulopathies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
75 Years
Study:
NCT00807703
Study Brief:
Protocol Section:
NCT00807703